🇺🇸 FDA
Patent

US 10081658

Truncated HIV envelope proteins (ENV), methods and compositions related thereto

granted A61KA61K2039/53A61K39/12

Quick answer

US patent 10081658 (Truncated HIV envelope proteins (ENV), methods and compositions related thereto) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/53, A61K39/12, A61K39/21, A61P